TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.42%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| 1 |
Apple
AAPL
|
$257M |
| 2 |
UnitedHealth
UNH
|
$226M |
| 3 |
Colgate-Palmolive
CL
|
$217M |
| 4 |
Moody's
MCO
|
$203M |
| 5 |
Curtiss-Wright
CW
|
$189M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$744M |
| 2 |
Lam Research
LRCX
|
$339M |
| 3 |
Merck
MRK
|
$305M |
| 4 |
Vistra
VST
|
$200M |
| 5 |
ConocoPhillips
COP
|
$181M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1301
DELISTED
Patterson Companies, Inc.
PDCO
| $492K | ﹤0.01% |
22,200
| – | – |
|
|
RGLS
1302
DELISTED
Regulus Therapeutics
RGLS
| $486K | ﹤0.01% |
+302,000
| New | +$486K |
|
1303
Otter Tail
OTTR
$3.54B
| $476K | ﹤0.01% |
6,100
-2,600
| -30% | -$203K |
|
1304
Kyverna Therapeutics
KYTX
$157M
| $472K | ﹤0.01% |
90,242
| – | – |
|
1305
British American Tobacco
BTI
$121B
| $466K | ﹤0.01% |
12,659
+210
| +2% | +$7.74K |
|
1306
Blue Foundry Bancorp
BLFY
$204M
| $466K | ﹤0.01% |
44,650
| – | – |
|
1307
InterDigital
IDCC
$7.43B
| $465K | ﹤0.01% |
3,300
-1,500
| -31% | -$212K |
|
|
NOA
1308
North American Construction
NOA
$393M
| $465K | ﹤0.01% |
24,668
-20
| -0.1% | -$377 |
|
1309
Orchestra BioMed
OBIO
$148M
| $465K | ﹤0.01% |
92,678
| – | – |
|
1310
National Grid
NGG
$68.4B
| $461K | ﹤0.01% |
6,917
+41
| +0.6% | +$2.73K |
|
1311
Bio-Rad Laboratories Class A
BIO
$7.83B
| $448K | ﹤0.01% |
1,349
-4,001
| -75% | -$1.33M |
|
|
CLYM
1312
Climb Bio, Inc. Common Stock
CLYM
$158M
| $445K | ﹤0.01% |
+89,400
| New | +$445K |
|
1313
Janux Therapeutics
JANX
$1.44B
| $441K | ﹤0.01% |
9,534
-10,266
| -52% | -$475K |
|
1314
Mr. Cooper
COOP
$13B
| $437K | ﹤0.01% |
4,800
-700
| -13% | -$63.7K |
|
|
SAGE
1315
DELISTED
Sage Therapeutics
SAGE
| $419K | ﹤0.01% |
57,474
| – | – |
|
1316
DNOW Inc
DNOW
$1.68B
| $417K | ﹤0.01% |
32,500
-12,000
| -27% | -$154K |
|
|
VSTO
1317
DELISTED
Vista Outdoor Inc.
VSTO
| $413K | ﹤0.01% |
10,500
| – | – |
|
1318
TTM Technologies
TTMI
$4.76B
| $407K | ﹤0.01% |
+21,900
| New | +$407K |
|
1319
Immuneering
IMRX
$233M
| $401K | ﹤0.01% |
150,876
| – | – |
|
|
LAR
1320
Lithium Argentina AG
LAR
$540M
| $401K | ﹤0.01% |
123,028
+253
| +0.2% | +$824 |
|
1321
Quanex
NX
$961M
| $398K | ﹤0.01% |
14,400
-9,800
| -40% | -$271K |
|
1322
Xponential Fitness
XPOF
$302M
| $398K | ﹤0.01% |
+32,400
| New | +$398K |
|
|
OBE
1323
Obsidian Energy
OBE
$405M
| $398K | ﹤0.01% |
72,067
-1,107
| -2% | -$6.12K |
|
1324
Zentalis Pharmaceuticals
ZNTL
$128M
| $398K | ﹤0.01% |
106,080
+3,200
| +3% | +$12K |
|
1325
Custom Truck One Source
CTOS
$1.39B
| $396K | ﹤0.01% |
+110,048
| New | +$396K |
|